Mutation of Arginine 264 on ERα (Estrogen Receptor Alpha) Selectively Abrogates the Rapid Signaling of Estradiol in the Endothelium Without Altering Fertility

Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2143-2158. doi: 10.1161/ATVBAHA.120.314159. Epub 2020 Jul 9.

Abstract

Objective: ERα (estrogen receptor alpha) exerts nuclear genomic actions and also rapid membrane-initiated steroid signaling. The mutation of the cysteine 451 into alanine in vivo has recently revealed the key role of this ERα palmitoylation site on some vasculoprotective actions of 17β-estradiol (E2) and fertility. Here, we studied the in vivo role of the arginine 260 of ERα which has also been described to be involved in its E2-induced rapid signaling with PI-3K (phosphoinositide 3-kinase) as well as G protein in cultured cell lines. Approach and Results: We generated a mouse model harboring a point mutation of the murine counterpart of this arginine into alanine (R264A-ERα). In contrast to the C451A-ERα, the R264A-ERα females are fertile with standard hormonal serum levels and normal control of hypothalamus-pituitary ovarian axis. Although R264A-ERα protein abundance was normal, the well-described membrane ERα-dependent actions of estradiol, such as the rapid dilation of mesenteric arteries and the acceleration of endothelial repair of carotid, were abrogated in R264A-ERα mice. In striking contrast, E2-regulated gene expression was highly preserved in the uterus and the aorta, revealing intact nuclear/genomic actions in response to E2. Consistently, 2 recognized nuclear ERα-dependent actions of E2, namely atheroma prevention and flow-mediated arterial remodeling were totally preserved.

Conclusions: These data underline the exquisite role of arginine 264 of ERα for endothelial membrane-initiated steroid signaling effects of E2 but not for nuclear/genomic actions. This provides the first model of fertile mouse with no overt endocrine abnormalities with specific loss-of-function of rapid ERα signaling in vascular functions.

Keywords: arginine; endothelium; estradiol; estrogen receptor alpha; fertility; mice; vascular diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology
  • Atherosclerosis / prevention & control
  • Carotid Artery Injuries / drug therapy*
  • Carotid Artery Injuries / metabolism
  • Carotid Artery Injuries / pathology
  • Carotid Artery Injuries / physiopathology
  • Cell Proliferation / drug effects
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / injuries
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiopathology
  • Enzyme Activation
  • Estradiol / pharmacology*
  • Estrogen Receptor alpha / agonists*
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor alpha / metabolism
  • Estrogen Replacement Therapy*
  • Estrogens / pharmacology*
  • Estrous Cycle / drug effects
  • Female
  • Fertility / drug effects*
  • Male
  • Mesenteric Arteries / drug effects*
  • Mesenteric Arteries / metabolism
  • Mesenteric Arteries / physiopathology
  • Mice, Inbred C57BL
  • Nitric Oxide Synthase Type III / metabolism
  • Ovariectomy
  • Point Mutation*
  • Re-Epithelialization / drug effects
  • Signal Transduction
  • Time Factors
  • Uterus / drug effects
  • Uterus / metabolism
  • Vascular Remodeling / drug effects
  • Vasodilation / drug effects

Substances

  • Esr1 protein, mouse
  • Estrogen Receptor alpha
  • Estrogens
  • Estradiol
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse